Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Multiple Rising Doses of BI 409306

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

May 1, 2012

Primary Completion Date

August 1, 2012

Study Completion Date

August 1, 2012

Conditions

Healthy

Interventions

DRUG

BI 409306

Film-coated tablet

DRUG

Placebo

Elderly healthy subjects received 50 mg of BI 409306 film-coated tablets orally after an overnight fast once daily for 14 days

Trial Locations (1)

1289.17.1 Boehringer Ingelheim Investigational Site, Neuss